SUBSCRIBE
SUBSCRIBE

Tennessee

Business partners shaking hands after closing a deal
Mergers & acquisitions
Crown Laboratories to Buy Botox Rival Revance Therapeutics for $924M
The acquisition announced Monday will give Crown access to Revance’s Daxxify, a competitor to AbbVie’s Botox, which is indicated for frown lines and for cervical dystonia.
August 13, 2024
 · 
2 min read
 · 
Tristan Manalac
PRESS RELEASES
Press Releases
Healthcare Integrated Technologies Inc. Announces Corporate Name Change to SafeSpace Global Corporation and Ticker Symbol Update
April 24, 2025
 · 
2 min read
Press Releases
Daxor Corporation to Exhibit at the 45th International Society for Heart and Lung Transplant (ISHLT) Annual Meeting and Scientific Sessions
April 23, 2025
 · 
3 min read
Press Releases
Daxor Corporation to Showcase Innovative Blood Volume Analysis at MedAxiom Cardiovascular Transforum Spring 2025
April 17, 2025
 · 
4 min read
Press Releases
New Research at ACC25 Shows Daxor BVA-Identified Euvolemic Heart Failure Patients Experience 2.61 Times Better Survival
April 16, 2025
 · 
4 min read
Press Releases
NHI Announces First Quarter 2025 Earnings Release and Conference Call Dates
April 15, 2025
 · 
1 min read
Press Releases
Daxor Corporation Submits 510(k) to FDA for Next-Generation Blood Volume Analyzer
April 11, 2025
 · 
3 min read
Press Releases
Vanderbilt Health Performs First Successful Kidney Transplant Using New Organ Preservation Technology
April 4, 2025
 · 
3 min read
Press Releases
Therapixel and Onsite Women’s Health Announce Partnership to Deploy MammoScreen® AI for Enhanced Breast Cancer Detection Across National Provider Network
April 3, 2025
 · 
3 min read
Press Releases
Daxor Corporation Announces New Data from Duke University and Highlights Key BVA Insights at American College of Cardiology’s 74th Annual Scientific Session and Expo
April 2, 2025
 · 
4 min read
Press Releases
Harrow Announces Transitional Pass-Through Reimbursement Status for TRIESENCE® (Triamcinolone Acetonide Injectable Suspension) 40 mg/mL
March 25, 2025
 · 
7 min read
Press Releases
Enigma Biomedical USA, Inc. Announces Candidate Selection of Novel 4R Tau PET Imaging Biomarkers
March 21, 2025
 · 
2 min read
Press Releases
Currax Secures Reliable and Consistent Supply of CONTRAVE®/MYSIMBA with FDA Approval for Second Manufacturing Site
March 20, 2025
 · 
8 min read
Press Releases
Currax Secures Reliable and Consistent Supply of CONTRAVE®/MYSBIMA with FDA Approval for Second Manufacturing Site
March 20, 2025
 · 
8 min read
Press Releases
NHI Announces $46.3 Million Senior Housing Investment
March 17, 2025
 · 
7 min read
Press Releases
FOXO TECHNOLOGIES INC. PROVIDES UPDATE ON ITS BEHAVIORAL HEALTH SUBSIDIARY, MYRTLE RECOVERY CENTERS, INC.
March 12, 2025
 · 
3 min read
Press Releases
Currax Pharmaceuticals: Peer-Reviewed Study in Obesity Pillars Further Substantiates Cardiovascular Safety Profile of CONTRAVE®/MYSIMBA®
March 12, 2025
 · 
8 min read
Press Releases
Harrow Executes Five-Year Strategic Supply and Development Agreement for TRIESENCE®
March 11, 2025
 · 
6 min read
Press Releases
Daxor Corporation to Host Investor Conference Call to Discuss Fiscal Year 2024 Financial Results and Provide a Corporate Update on March 6, 2025
March 5, 2025
 · 
2 min read
Press Releases
Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders
March 4, 2025
 · 
13 min read
Press Releases
Daxor Corporation Reports Increase in NAV to $7.25 Per Share and 116.5 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2023
March 4, 2025
 · 
4 min read
Load More